市場調查報告書

全球miRNA序列·化驗市場:成長,趨勢,及預測

miRNA Sequencing and Assay Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 922020
出版日期 內容資訊 英文 109 Pages
商品交期: 2-3個工作天內
價格
全球miRNA序列·化驗市場:成長,趨勢,及預測 miRNA Sequencing and Assay Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 109 Pages
簡介

本報告提供全球miRNA序列·化驗市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各產品·技術·終端用戶·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • MiRNA序列·化驗序列的優勢
    • 通過增加基因組學領域的研究來增加miRNA測序的採用
    • 削減序列成本
  • 市場阻礙因素
    • 缺乏專家
  • 波特的五力分析

第5章 市場區隔

  • 各產品
    • 消耗品
    • 程序庫製作
  • 各技術
    • 合成的序列
    • 離子半導體序列
    • SOLiD
    • 奈米細孔序列
  • 各終端用戶
    • 臨床檢驗室
    • 生命科學機構
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Illumina, Inc.
    • Thermo Fisher Scientific
    • Qiagen NV
    • PerkinElmer, Inc.
    • TaKaRa BIO株式會社
    • New England Biolabs, Inc.
    • Norgen Biotek Corporation
    • Trilink Biotechnologies
    • Lexogen
    • Oxford Nanopore Technologies

第7章 市場機會及今後趨勢

目錄
Product Code: 67526

Market Overview

The miRNA Sequencing and Assay market is anticipated to grow with a CAGR of 10.9%, during the forecast period. The significant factor attributing to the growth is the rising prevalence of infectious diseases, the development of novel technology and the introduction of different techniques to assess the miRNA sequence will boost the market growth for miRNA sequencing and assay market during the forecast market. In the diagnostics and prognostics industry, the miRNA sequencing method has the ability to become an essential tool. Increasing popularity for cost-effective sequencing methods, rising cancer incidence, and increasing activities in genomics research will also propel the market demand for miRNA sequencing and assay in the coming years.

Scope of the Report

miRNA sequencing is a type of RNA-seq, which uses the next-generation sequencing or massively parallel sequencing of high-throughput DNA to pattern microRNAs. The substance used during the method of decoding miRNA; this sequencing is a bit different from RNA sequencing.

Key Market Trends

Library preparation kits are Expected to Hold the Largest Market Share in the miRNA Sequencing and Assay Market

  • Dominant share is retained by the library preparation kits segment owing to the attributes such as rising genome-related research and growing cancer research and owing to the high demand for next-generation sequencing technology for all the research because it has the ability to deliver the potential healthcare solution.
  • The growth of the segment can be also attributed to the high prevalence of chronic diseases such as cancer and infectious diseases. Rising chronic diseases are a global challenge, account for around 60% of all fatalities globally, as per the WHO estimates.
  • As per the statistics from GLOBOCAN 2018, worldwide 2,088,849 individuals have breast cancer. Asia remains the leading contributor in the rising incidence of breast cancer with a reported share of 43.6% followed by Europe, North and Latin America, Africa, and Oceania with a share of 25%, 12.6% and 9.6%, 8.1%, and 1.2% respectively.

North America Dominates the Market and Expected to do Same in the Forecast Period

Owing to the increasing adoption of advanced technologies, this region is gaining a high market share. This is owing to factors such as rising initiatives to carry out research and development activities are the key factor in this market's growth in the region. Growing numbers of infectious diseases are the key driver of market growth. However, the demand is driven by rising incidence cases of cancer. Factors such as the availability of world-class academics and research facilities committed to genome research increased government funding for genetic research, and increased demand for technological, high-throughput technologies for miRNA research are additional factors boosting the region share at the global level during the forecast period.

Competitive Landscape

The miRNA sequencing and assay market is moderately competitive and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions with the other companies and launching new products to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Illumina, Inc., Thermo Fisher Scientific, Qiagen N.V., Perkinelmer, Inc., and Takara Bio, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 MiRNA Sequencing and Assay Sequencing supremacy over other methods
    • 4.2.2 Increased research in the field of genomics drive the miRNA sequencing adoption
    • 4.2.3 Reduced sequencing costs
  • 4.3 Market Restraints
    • 4.3.1 Paucity of professional experts
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Sequencing Consumables
    • 5.1.2 Library Preparation Kits
  • 5.2 By Technology
    • 5.2.1 Sequencing by Synthesis
    • 5.2.2 Ion Semiconductor
    • 5.2.3 SOLiD
    • 5.2.4 Nanopore Sequencing
  • 5.3 By End User
    • 5.3.1 Clinical Laboratory
    • 5.3.2 Life Science Organization
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Illumina, Inc.
    • 6.1.2 Thermo Fisher Scientific
    • 6.1.3 Qiagen N.V.
    • 6.1.4 PerkinElmer, Inc.
    • 6.1.5 Takara Bio, Inc.
    • 6.1.6 New England Biolabs, Inc.
    • 6.1.7 Norgen Biotek Corporation
    • 6.1.8 Trilink Biotechnologies
    • 6.1.9 Lexogen
    • 6.1.10 Oxford Nanopore Technologies

7 MARKET OPPORTUNITIES AND FUTURE TRENDS